NCT04411953View on ClinicalTrials.gov

Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Bioequivalence
Interventions
DRUG

Haloperidol Tablets, Mylan Pharmaceuticals Inc.

single dose, 2 mg Haloperidol tablet

DRUG

Haloperidol Tablets, Cycle Pharmaceuticals Ltd

single dose, 2 mg Haloperidol tablet

Trial Locations (1)

9301

FARMOVS Clinical Research Organisation, Bloemfontein

Sponsors

Collaborators (1)

Farmovs
All Listed Sponsors
collaborator

Farmovs

INDUSTRY

lead

Cycle Pharmaceuticals Ltd.

INDUSTRY